Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF

Anthony J. Hutchinson, Chih Ling Chou, Davelene D. Israel, Wei Xu, John W Regan

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Prostaglandin E2 (PGE2) is produced at high levels in the injured central nervous system, where it is generally considered a cytotoxic mediator of inflammation. The cellular actions of PGE2 are mediated by G-protein signaling activated by prostanoid receptors termed EP1, EP2, EP3 and EP4. Recent studies have implicated the EP2 prostanoid receptor to be in apparently conflicting roles promoting neuronal death in some model systems and the survival of neurons in others. Here we show that treatment of immortalized human microglia and CCF-STTG1 astrocytes with either PGE2 or the EP2 selective agonist butaprost stimulates the release of brain-derived neurotrophic factor (BDNF). Both cell lines express mRNA for the EP2 receptor, whereas transcripts for the other subtypes are not detected. Pharmacological studies using PGE2 and modulators of cyclic AMP signaling implicate this pathway in PGE2-stimulated BDNF release. These results indicate that EP2 prostanoid receptor activation induces BDNF secretion through stimulation of cyclic AMP dependent signaling. Our findings provide a mechanism by which endogenous PGE2 might contribute to either neurotoxicity or neuroprotection in the injured brain via the induction of BDNF release from microglial cells and astrocytes.

Original languageEnglish (US)
Pages (from-to)439-446
Number of pages8
JournalNeurochemistry International
Volume54
Issue number7
DOIs
StatePublished - Jun 2009

Fingerprint

Receptors, Prostaglandin E, EP2 Subtype
Brain-Derived Neurotrophic Factor
Dinoprostone
Neuroglia
Cell Line
Astrocytes
Cyclic AMP
Receptors, Prostaglandin E, EP1 Subtype
Inflammation Mediators
Microglia
GTP-Binding Proteins
Central Nervous System
Pharmacology
Neurons
Messenger RNA
Brain

Keywords

  • Astrocytes
  • BDNF
  • Brain-derived neurotrophic factor
  • Cyclic AMP
  • G-protein coupled receptor
  • Microglia
  • Prostaglandin E

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF. / Hutchinson, Anthony J.; Chou, Chih Ling; Israel, Davelene D.; Xu, Wei; Regan, John W.

In: Neurochemistry International, Vol. 54, No. 7, 06.2009, p. 439-446.

Research output: Contribution to journalArticle

Hutchinson, Anthony J. ; Chou, Chih Ling ; Israel, Davelene D. ; Xu, Wei ; Regan, John W. / Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF. In: Neurochemistry International. 2009 ; Vol. 54, No. 7. pp. 439-446.
@article{2f3fa84a4c2e4c6d85134f716348cb6a,
title = "Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF",
abstract = "Prostaglandin E2 (PGE2) is produced at high levels in the injured central nervous system, where it is generally considered a cytotoxic mediator of inflammation. The cellular actions of PGE2 are mediated by G-protein signaling activated by prostanoid receptors termed EP1, EP2, EP3 and EP4. Recent studies have implicated the EP2 prostanoid receptor to be in apparently conflicting roles promoting neuronal death in some model systems and the survival of neurons in others. Here we show that treatment of immortalized human microglia and CCF-STTG1 astrocytes with either PGE2 or the EP2 selective agonist butaprost stimulates the release of brain-derived neurotrophic factor (BDNF). Both cell lines express mRNA for the EP2 receptor, whereas transcripts for the other subtypes are not detected. Pharmacological studies using PGE2 and modulators of cyclic AMP signaling implicate this pathway in PGE2-stimulated BDNF release. These results indicate that EP2 prostanoid receptor activation induces BDNF secretion through stimulation of cyclic AMP dependent signaling. Our findings provide a mechanism by which endogenous PGE2 might contribute to either neurotoxicity or neuroprotection in the injured brain via the induction of BDNF release from microglial cells and astrocytes.",
keywords = "Astrocytes, BDNF, Brain-derived neurotrophic factor, Cyclic AMP, G-protein coupled receptor, Microglia, Prostaglandin E",
author = "Hutchinson, {Anthony J.} and Chou, {Chih Ling} and Israel, {Davelene D.} and Wei Xu and Regan, {John W}",
year = "2009",
month = "6",
doi = "10.1016/j.neuint.2009.01.018",
language = "English (US)",
volume = "54",
pages = "439--446",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF

AU - Hutchinson, Anthony J.

AU - Chou, Chih Ling

AU - Israel, Davelene D.

AU - Xu, Wei

AU - Regan, John W

PY - 2009/6

Y1 - 2009/6

N2 - Prostaglandin E2 (PGE2) is produced at high levels in the injured central nervous system, where it is generally considered a cytotoxic mediator of inflammation. The cellular actions of PGE2 are mediated by G-protein signaling activated by prostanoid receptors termed EP1, EP2, EP3 and EP4. Recent studies have implicated the EP2 prostanoid receptor to be in apparently conflicting roles promoting neuronal death in some model systems and the survival of neurons in others. Here we show that treatment of immortalized human microglia and CCF-STTG1 astrocytes with either PGE2 or the EP2 selective agonist butaprost stimulates the release of brain-derived neurotrophic factor (BDNF). Both cell lines express mRNA for the EP2 receptor, whereas transcripts for the other subtypes are not detected. Pharmacological studies using PGE2 and modulators of cyclic AMP signaling implicate this pathway in PGE2-stimulated BDNF release. These results indicate that EP2 prostanoid receptor activation induces BDNF secretion through stimulation of cyclic AMP dependent signaling. Our findings provide a mechanism by which endogenous PGE2 might contribute to either neurotoxicity or neuroprotection in the injured brain via the induction of BDNF release from microglial cells and astrocytes.

AB - Prostaglandin E2 (PGE2) is produced at high levels in the injured central nervous system, where it is generally considered a cytotoxic mediator of inflammation. The cellular actions of PGE2 are mediated by G-protein signaling activated by prostanoid receptors termed EP1, EP2, EP3 and EP4. Recent studies have implicated the EP2 prostanoid receptor to be in apparently conflicting roles promoting neuronal death in some model systems and the survival of neurons in others. Here we show that treatment of immortalized human microglia and CCF-STTG1 astrocytes with either PGE2 or the EP2 selective agonist butaprost stimulates the release of brain-derived neurotrophic factor (BDNF). Both cell lines express mRNA for the EP2 receptor, whereas transcripts for the other subtypes are not detected. Pharmacological studies using PGE2 and modulators of cyclic AMP signaling implicate this pathway in PGE2-stimulated BDNF release. These results indicate that EP2 prostanoid receptor activation induces BDNF secretion through stimulation of cyclic AMP dependent signaling. Our findings provide a mechanism by which endogenous PGE2 might contribute to either neurotoxicity or neuroprotection in the injured brain via the induction of BDNF release from microglial cells and astrocytes.

KW - Astrocytes

KW - BDNF

KW - Brain-derived neurotrophic factor

KW - Cyclic AMP

KW - G-protein coupled receptor

KW - Microglia

KW - Prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=63149170429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63149170429&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2009.01.018

DO - 10.1016/j.neuint.2009.01.018

M3 - Article

C2 - 19428786

AN - SCOPUS:63149170429

VL - 54

SP - 439

EP - 446

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 7

ER -